|
Originally published In Press as doi:10.1074/jbc.M206483200 on July 10, 2002
J. Biol. Chem., Vol. 277, Issue 38, 35597-35604, September 20, 2002
Properties of Long Myosin Light Chain Kinase Binding to
F-Actin in Vitro and in Vivo*
Lula
Smith §,
Mojgan
Parizi-Robinson ,
Min-Sheng
Zhu ,
Gang
Zhi,
Ryosuke
Fukui,
Kristine E.
Kamm, and
James T.
Stull¶
From the Department of Physiology, University of Texas Southwestern
Medical Center, Dallas, Texas 75390-9040
Received for publication, June 30, 2002
 |
ABSTRACT |
Short and long myosin light chain kinases (MLCKs)
are Ca2+/calmodulin-dependent enzymes
that phosphorylate the regulatory light chain of myosin II in thick
filaments but bind with high affinity to actin thin filaments. Three
repeats of a motif made up of the sequence DFRXXL at the N
terminus of short MLCK are necessary for actin binding (Smith, L., Su,
X., Lin, P., Zhi, G., and Stull, J. T. (1999) J. Biol.
Chem. 274, 29433-29438). The long MLCK has two additional
DFRXXL motifs and six Ig-like modules in an N-terminal extension, which may confer unique binding properties for cellular localization. Two peptides containing either five or three
DFRXXL motifs bound to F-actin and smooth muscle
myofilaments with maximal binding stoichiometries consistent with each
motif binding to an actin monomer in the filaments. Both peptides
cross-linked F-actin and bound to stress fibers in cells. Long MLCK
with an internal deletion of the five DFRXXL motifs and the
unique NH2-terminal fragment containing six Ig-like motifs
showed weak binding. Cell fractionation and extractions with
MgCl2 indicate that the long MLCK has a greater affinity
for actin-containing filaments than short MLCK in vitro and
in vivo. Whereas DFRXXL motifs are necessary and sufficient for short MLCK binding to actin-containing filaments, the DFRXXL motifs and the N-terminal extension of long MLCK
confer high affinity binding to stress fibers in cells.
 |
INTRODUCTION |
MLCK,1 a dedicated
protein kinase activated by Ca2+/calmodulin, phosphorylates
the regulatory light chain of myosin II. This signaling event enhances
actin-activated myosin ATPase activity that mediates contraction in
smooth muscle cells (2-4). MLCK is also important in regulating
diverse cellular functions that rely on interactions of myosin II with
the actin cytoskeleton (4).
Vertebrate smooth muscle MLCK exists in two isoforms, which are
products of a single gene (5-7). The low molecular weight isoform MLCK
(short MLCK) has a molecular mass of ~150 kDa, whereas the high
molecular weight isoform (long MLCK) has a larger molecular mass of
about 210 kDa because of an extended N terminus (3, 6, 8). The
terminology short and long smooth muscle MLCKs was proposed to identify
these two proteins expressed from a single gene (4). Both short and
long MLCKs are expressed in embryonic and adult nonmuscle as well as
smooth muscle cells; thus, terms such as embryonic and endothelial
MLCKs are too restrictive. Identification by size is confusing because
molecular mass can vary from 101,423 to 128,825 kDa for short MLCK from
different animal species (9, 10). Terminology becomes even more
confusing when molecular mass values are mixed with relative masses
determined by SDS-PAGE where Mr values are
significantly greater than molecular mass values. For example, short
MLCK from rabbit has a predicted mass of 125,719 but its
Mr value is 150,000 kDa. MLCK isoforms are differentially expressed in smooth and striated muscles as well as
nonmuscle cells (3, 5, 11-13).
Interestingly, MLCK binds to actin thin filaments whereas its
substrate, myosin, is in thick filaments (14, 15). The actin-binding properties of the short MLCK are precisely identified with three repeated motifs of DFRXXL residues at the N terminus (1,
16). Additional structural motifs in the short MLCK,
including three immunoglobulin-like and one fibronectin
module in addition to PEVK tandem repeats, do not appear to be involved
in high-affinity binding to actin or myosin filaments (4).
The long MLCK is identical to the short MLCK except for an extended N
terminus with two additional putative actin-binding motifs in tandem
with the three demonstrated actin-binding motifs plus six additional
immunoglobulin-like modules. Four of its five actin-binding motifs
contain DFRXXL residues, whereas the most N-terminal motif
contains a conservative substitution in one residue, DVRXXL.
Because the short MLCK contains only DFRXXL and the
conservative substitution of valine for phenylalanine occurs in only
one of the five motifs, we will use a generic nomenclature of
DFRXXL for all of these motifs.
Although the actin-binding properties of short MLCK have been defined
in vitro and in vivo (1, 17, 18), it is not clear whether the five actin-binding motifs of long MLCK share an identical functional role in terms of binding abilities. Poperechnaya
et al. (19) found different distributions of the
MLCKs in HeLa cells with short MLCK, primarily cytoplasmic, in contrast
to long MLCK localized to stress fibers (19). However, short MLCK was localized to stress fibers in fibroblasts and A7r5 cells (1, 18).
Additionally, specific localization of the long MLCK to the cleavage
furrow in dividing cells required both the N-terminal extension with
six Ig-like modules and five DFRXXL motifs. Many actin-binding proteins modulate the function of actin filaments (20,
21). Accordingly, smooth muscle MLCK has been shown to cross-link actin
filaments into bundles (22-24). However, the region of the kinase
required for actin bundling has not been delineated.
To address these issues, we expressed peptides containing either three
or five actin-binding motifs and examined their biochemical properties
in vitro and in vivo. In addition, we
investigated binding properties of wild-type and mutated short and long
MLCKs in vivo (Fig. 1).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic representation of short and long
MLCK mutants and fusion proteins. The
short MLCK has a catalytic core (cyan) with a
C-terminal autoinhibitory linker region (yellow) and
calmodulin-binding sequence (red). Structural components
include actin-binding motifs (blue stripes) as well as PEVK
(loops), immunoglobulin-like (gold), and
fibronectin-like (blue) modules. GFP and
GST fusion proteins are shown in green and
black, respectively.
|
|
 |
EXPERIMENTAL PROCEDURES |
Construction of N-terminal MLCK Peptides--
A short MLCK
peptide containing residues 1-147 (3DFR-MLCK) was prepared using PCR
and the expanded high fidelity system (Roche Molecular Biochemicals). A
C-terminal His tag and a phosphorylation site corresponding to the
recognition site for protein kinase A was included in the construct
design as described (17). The primers were designed based on the
sequence of the cDNA of rabbit smooth muscle
MLCK. PCR reactions were performed for 35 cycles of
denaturing, annealing, and extension (95 °C, 45 s; 63 °C,
30 s; and 72 °C, 30 s). The final PCR product was digested
with NheI and XhoI and subcloned into pET-24a
expression vector (Novagen). An MLCK fragment containing the
five actin-binding motifs of the long MLCK was used to
prepare 5DFR-MLCK similar to 3DFR-MLCK. After the
PCR reaction was performed as described above, the fragment was
digested with EcoRI and BamHI and subcloned into
pDsRed1-N1 (CLONTECH) to produce a red fluorescent
protein fusion protein. Additionally the fragment was prepared
containing a C-terminal His tag and a phosphorylation site
corresponding to the recognition site for protein kinase A (17).
Construction of MLCK-GFP Mutants--
pEGFP-MLCK210
plasmid was originally constructed by Poperechnaya et al.
(19). The full-length coding region for chicken smooth muscle long
MLCK without a stop codon was inserted in
pEGFP-N1 vector (CLONTECH Inc.) between
the EGFP gene driven by a cytomegalovirus promoter. Two
extra guanine nucleotides were introduced immediately after 5718 nt of
the long MLCK gene to maintain reading frames for the two
genes. In cell studies, pEGFP-MLCK210 was used as wild-type
control (long MLCK-GFP). The 5 DFRXXL region
(2638 to 3033 nt) of long MLCK was deleted by PCR with the
long MLCK-GFP plasmid as a template and using primer pairs
5'-GCAAAATGAAGATATCTTCACACTG-3' and
5'-GCTAGCGGCGATCGCGAGTCTTCCTGCTCTTC-3'. In this fragment, an original
EcoRV site in the gene remained in the 5' end and an
NheI site was introduced in the 3' end. After subcloning in TOPO vector (CLONTECH Inc.), a 0.28-kb fragment was
produced by EcoRV and NheI digestion and ligated
to long MLCK-GFP vector in which a region between 2638 and
3033 nt was removed by EcoRV and NheI digestion.
The final construct ((-5DFR) long MLCK-GFP) was confirmed by sequencing.
To delete the region that contains 5DFR and the full-length short form
of MLCK (2638 to 5721 nt), a fragment corresponding to the
region 2361 to 2637 nt was first amplified by PCR with primer pairs
5'-GCAAAATGAAGATATCTTCACACTG-3' and
5'-GACGTCGACTAGGGATCCCCTTCCTGCTCTTCCTC-3' and an EcoRV site
and a BamHI site in the 5' and 3' termini, respectively. This fragment was subcloned into TOPO vector and confirmed by sequencing. It was removed from TOPO vector by EcoRV and
BamHI digestion and ligated with long MLCK-GFP
vector that was previously digested with EcoRV and
BamHI. The resultant fragment (N-term), long
MLCK-GFP, contained the N-terminal six Ig-like motifs of long MLCK.
Protein Expression--
Recombinant plasmids harboring
3DFR-MLCK or 5DFR-MLCK were transformed into
BL21(DE3) cells. Expression was induced with 1 mM
isopropyl-1-thio-D-galactopyranoside as described (17).
Cells were harvested at 8,000 × g for 10 min,
resuspended in 5 ml phosphate-buffered saline, 5 mM
dithiothreitol, 0.1% Nonidet P-40, 1 mM
phenylmethylsulfonyl fluoride, 20 µg/ml leupeptin, 20 µg/ml
pepstatin, and lysed by sonication at 4 °C. The lysed suspension was
then centrifuged at 10,000 × g for 10 min at 4 °C.
The supernatant fraction was filtered with a 0.45-µm filter (Nalgene)
and proteins were purified using histidine affinity column
chromatography (Novagen). The purified proteins were dialyzed against
20 mM MOPS, pH 7.5, 10 mM NaCl, 1 mM MgCl2, and 1 mM dithiothreitol
and stored at 80 °C. GST fusion peptides containing one, two, or
three DFRXXL motifs (GST-30, GST-55, and GST-75,
respectively) were expressed and purified as described previously
(1).
Phosphorylation of DFR-MLCK Peptides--
DFR-MLCKs at 50 µM were phosphorylated at the C-terminal sequence
LRRASLG by the catalytic subunit of protein kinase A (5 µg/100-µl reaction) in the presence of 100 µM ATP (15 µCi) in 10 mM Tris-HCl, pH 7.4, 5 mM
MgCl2, and 1 mM dithiothreitol. Most of the
unincorporated 32P was removed with spin columns containing
buffer used in the binding assays as previously described (17).
Extraction of Smooth Muscle Myofilaments--
Chicken gizzards
were homogenized in 10 mM MOPS, 50 mM NaCl, and
1 mM dithiothreitol at pH 7.5 with a Polytron homogenizer (Brinkmann Instruments). Homogenized tissue was centrifuged at 17,320 × g for 10 min at 4 °C. The pellets were
homogenized in 10 ml of 10 mM Tris-HCl, pH 7.5, 2 mM EGTA, 2 mM dithiothreitol, 50 mM
MgCl2, and 3% Triton X-100 to dissociate endogenous MLCK. After washing in the detergent-containing buffer five times, the myofilaments were then washed three times in 10 mM MOPS, pH
7.5, 50 mM NaCl, 1 mM dithiothreitol and stored
in the same buffer on ice.
Filament Binding--
A co-sedimentation assay was used to
characterize MLCK binding to smooth muscle myofilaments. Phosphorylated
DFR-MLCKs were mixed with 0.70 mg/ml myofilaments in a final volume of
150 µl. The mixture was incubated for 30 min at 4 °C in 10 mM imidazole, pH 7.2, 50 mM KCl, 1 mM MgCl2, 1 mM dithiothreitol, 0.1 mM EGTA, 10% glycerol, and 0.2 mg/ml bovine serum albumin.
The reactions were centrifuged at 17,320 × g for 5 min
at 4 °C. An aliquot of the supernatant fraction was spotted on
cellulose filter paper. The filters were then washed in phosphoric acid
to remove residual free ATP (17). The total reaction mixture was
treated similarly and the radioactivity was determined by liquid
scintillation spectrometry. The decrease in radioactivity in the
supernatant fractions compared with that in the total reaction mixtures
was used to calculate the bound MLCK. There was no evidence of DFR-MLCK
dephosphorylation upon incubation with myofilaments (17). Values of
KD and Bmax were calculated
for individual experiments subjected to Scatchard analysis. Binding to
F-actin was performed as previously reported (17).
F-Actin Cross-linking--
F-actin from rabbit skeletal muscle
was prepared (25). Increasing concentrations of DFR-MLCK peptides
(1-10 µM) were incubated with 6 µM F-actin
at 25 °C, for 1 h in 10 mM MOPS, 100 mM
NaCl, 1 mM EGTA, and 1 mM dithiothreitol. The
reaction mixture was centrifuged at 12,000 × g for 30 min. The pellet and supernatant fractions were resolved by SDS-PAGE and
immunoblotted with an actin monoclonal antibody. The relative actin
content in the pellet and supernatant fractions was quantified by densitometry.
Cell Culture and Transfection--
FuGENE 6 (Roche Molecular
Biochemicals) was used to transfect A7r5 or HeLa cells seeded in 60-mm
tissue culture dishes at a density of 6 × 105 in 5 ml
of Dulbecco's modified Eagle's medium, 10% fetal bovine serum, and
1% penicillin-streptomycin. The cells were incubated overnight at
37 °C and 12 µl of FuGENE 6 was mixed with 288 µl of serum-free
Dulbecco's modified Eagle's medium and incubated at room temperature
for 5 min. The FuGENE/Dulbecco's modified Eagle's medium mixture was
added to 3 µg of plasmid DNA. The mixture was then overlaid onto
cells at 65-75% confluency. Cells were incubated 48-72 h at
37 °C. For transfection with LipofectAMINE PlusTM
(Invitrogen), DNA was diluted into serum-free medium (4 µg of
DNA was diluted into 750 µl of serum-free medium), and mixed with 20 µl of LipofectAMINE Plus reagent for 15 min. The pre-complexed DNA
and the diluted LipofectAMINE reagent were mixed and incubated for 15 min and then incubated with A7r5 cells for 3 h, after which an
additional 5 ml of complete medium was added to cells.
Transfected cells were incubated at 37 °C and 5% CO2
for 2 days before experiments.
NIH3T3 cells were maintained in Dulbecco's modified Eagle's medium
containing 5% fetal bovine serum, 100 units/ml penicillin, and 100 µg/ml streptomycin at 37 °C with 5% CO2. For DNA
transfection, NIH3T3 cells were seeded onto 40-mm round coverslips (40 circles-1D; Fisher) in 60-mm Petri dishes at 20-30% confluence
1 day before transfection. LipofectAMINE was used for DNA transfection
as described above. COS-7 cells were transfected by similar procedures
and harvested between 1 and 3 days.
Cell Imaging--
Fluorescence imaging was performed as
described previously (26). Twelve-bit images were obtained with a CCD
camera (Quantix Photometrics, Tucson, AZ) and Oncor-image software
(Oncor, Gaithersburg, MD). Narrow bandpass interference filters (Omega,
Brattleboro, VT) were used to detect GFP (490 nm excitation and 520 nm
emission) and rhodamine (550 nm excitation and 575 nm emission). During image collection, cells were kept at 37 °C in an open
thermal-controlled chamber (Custom Scientific, Dallas, TX). Cells were
subsequently treated with a buffer containing 0.02% saponin in 20 mM PIPES, pH 6.8, 4 mM EGTA, 90 mM
K+-gluconate, 5.3 mM Na2ATP, 5 mM MgS04, 0.1% bovine serum albumin, 0.1 mM phenylmethylsulfonyl fluoride, and 10 mg/ml leupeptin
for 10 min at 37 °C. The cells were then washed several times with the buffer in the absence of saponin and images were obtained.
Actin Filaments in Cells--
Medium was removed from
tissue culture dishes and replaced with 10 µM
lysophosphatidic acid or 1 µM latrunculin B in serum-free media for 1 h before microscopy. Populations of actin filaments in
cells were separated by differential centrifugation (27). Cells were
lysed in 10 mM MOPS, pH 7.0, 1.0% Triton-X-100, 10% glycerol, 0.5 mM EDTA, 10 mM sodium
pyrophosphate, 50 mM sodium fluoride, 1 mM
sodium orthovanadate, 1 mM dithiothreitol, and protease
inhibitors (100 µg/ml phenylmethanesulfonyl fluoride, 20 µg/ml
leupeptin, 30 µg/ml aprotinin, 0.5 mg/ml diisopropyl fluorophosphate,
0.2 mg/ml
trans-epoxysuccinyl-L-leucylamido(guanidino)butane). The lysates were centrifuged at 16,000 × g for 2 min.
The pellet fraction contains Triton-insoluble cytoskeleton fibers
(P1). The supernatant fraction was centrifuged at
100,000 × g for 20 min. The second pellet fraction
contains Triton-soluble filamentous actin (P2), whereas the
supernatant fraction (S) contains soluble G-actin. The three fractions
were analyzed by Western blotting. Monoclonal antibodies against smooth
muscle MLCK, GFP, or actin were used as primary antibodies and goat
anti-mouse monoclonal secondary antibody-horseradish peroxidase was
used with the ECL system for visualization.
Short and long MLCKs were dissociated from cellular actin filaments by
MgCl2. In additional experiments short MLCK, long MLCK, 3DFR-MLCK, 5DFR-MLCK, (-5DFR) long MLCK, and (N-term) long MLCK as GFP
fusion proteins were expressed in COS cells. A10 cells containing both
short and long MLCKs or transfected COS-7 cells were lysed in 50 mM MOPS, pH 7.5, containing 0.5 mM EGTA, 1%
Triton X-100, and protease inhibitors, 0.5 mM diisopropyl
fluorophosphate and 0.5 mM
trans-epoxysuccinyl-L-leucylamido(guanidino)butane. In additional experiments, rabbit lung tissue was homogenized in the
same buffer (10 mg of tissue was homogenized in 600 µl of buffer).
Appropriate aliquots from each sample were incubated in the lysis
buffer with different concentrations of MgCl2 for 20 min on
ice. The samples were then centrifuged at 100,000 × g
for 20 min at 4 °C. Subsequently, the supernatant fractions were
diluted with SDS sample buffer, resolved by SDS-PAGE, and further
analyzed by Western blotting.
 |
RESULTS |
DFR-MLCK Peptides Bind to Actin Filaments--
We previously
showed using a cosedimentation assay that the three DFRXXL
motifs in the N terminus of short MLCK constitute high affinity binding
of MLCK to actomyosin filaments from smooth muscle (1, 17). Here we
focused on the properties of the two additional motifs found in long
MLCK. Fig. 2 and Table
I show that both MLCK peptides have
similar KD values of about 0.25 µM.
The stoichiometry of binding, on the other hand, was significantly
different. The maximal amount of 5DFR-MLCK binding was 0.21 mol of
peptide/mol of actin, whereas maximal binding for 3DFR-MLCK was 0.33 mol of peptide/mol of actin. Similar results were obtained with F-actin
filaments (Table I). These results support a model in which each
DFRXXL motif in both long and short MLCK binds per one actin
monomer in actin filaments (16, 17). The similarity in the apparent
KD values for 3DFR-MLCK versus 5DFR-MLCK
was surprising, so additional experiments were performed with expressed
peptides as well as other MLCK fragments to measure binding to actin
containing stress fibers (see below).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
DFR-MLCK peptides bind to smooth muscle
myofilaments. Increasing concentrations of 3DFR-MLCK or 5DFR-MLCK
were mixed with 3 µM actin in myofilaments for
co-precipitation experiments as described under "Experimental
Procedures." The amount of 3DFR-MLCK or 5DFR-MLCK bound (mol
MLCK/mol actin) is plotted against the DFR-MLCK peptide
concentration. , 3DFR-MLCK; , 5DFR-MLCK. Data representative of
at least 5 experiments are shown.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Binding properties of MLCK peptides
The DFR-MLCK peptides were incubated with detergent-washed smooth
muscle myofilaments or F-actin as described under "Experimental
Procedures." After centrifugation the amount of bound peptide was
measured for determination of KD and
Bmax values as shown in Fig. 2. Numbers represent
the mean ± S.E. for at least 5 measurements.
|
|
Actin Cross-linking--
To assess the ability of the
DFRXXL motifs of MLCK to cross-link actin filaments without
additional structural modules found in full-length kinases, we
conducted a low speed centrifugation assay in which increasing
concentrations of peptides were incubated with a fixed concentration of
F-actin (6 µM). F-actin was not found in the pellet under
these conditions but sediments when proteins cross-link filaments
because of multiple actin-binding sites in a single polypeptide (20,
28, 29). As shown in Fig. 3A,
the amount of actin obtained in the pellet fraction was similar for
both 3DFR-MLCK and 5DFR-MLCK at similar concentrations of peptides.
Fig. 3B shows that a GST fusion protein containing one
complete DFRXXL motif (GST30-MLCK) did not cross-link actin nor did GST itself. MLCK GST fusion peptide containing two
DFRXXL motifs within residues 1-55 (GST55-MLCK)
cross-linked 50% of the actin compared with ~90% with GST75-MLCK
that contains all three actin-binding motifs. The latter value was
similar to maximal effects observed with 3DFR-MLCK and 5DFR-MLCK. These
results indicate that the peptides containing multiple
DFRXXL actin binding sequences and flanking residues are
sufficient for cross-linking actin filaments.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Actin cross-linking by DFR-MLCK peptides.
A, F-actin filaments (6 µM) were mixed
with increasing concentrations of 3DFR-MLCK or 5DFR-MLCK. The reaction
was incubated at 25 °C for 1 h to assemble the filaments into
bundles. After low speed centrifugation, the pellet and supernatant
fractions were analyzed by Western blotting and the actin content was
determined by densitometry. Each point corresponds to the mean ± S.E. (n = 3). , 3DFR-MLCK; ,
5DFR-MLCK. B, actin filaments (6 µM) were mixed with 2 µM
GST75-MLCK (GST75), GST55-MLCK
(GST55), GST30-MLCK (GST30), or
GST alone. F-actin alone was also analyzed. The measurements
were performed as described in A.
|
|
In Vivo Localization of 3DFR-MLCK and 5DFR-MLCK--
To analyze
the localization of 3DFR-MLCK and 5DFR-MLCK in cultured cells,
fluorescent proteins were fused to the C terminus of 3DFR-MLCK or
5DFR-MLCK, respectively. At similar levels of expression after
transfection, the 3DFR-MLCK peptide localized to stress fibers in A7r5
cells, and 5DFR-MLCK displayed a similar pattern (Fig.
4). However, 5DFR-MLCK appeared to have
more prominent fluorescence staining on stress fibers in HeLa cells
compared with 3DFR-MLCK. When cells were made permeable with saponin,
the fluorescence remained associated with stress fibers for both
peptides, indicating high affinity binding to actin-containing stress
fibers. The fluorescence of GFP itself was diffusely distributed
throughout the cytoplasm, and treatment with saponin resulted in loss
of fluorescence (data not shown) (1). These results show that peptides
containing three or five DFRXXL motifs are sufficient for
binding to actin filaments in both smooth and nonmuscle cells.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 4.
Cellular localization of 3DFR-MLCK
and 5DFR-MLCK. A7r5 cells or HeLa cells
were transfected independently with plasmids for 3DFR-MLCK
or 5DFR-MLCK. The top panels are images of intact
cells and the bottom panels are images acquired after the
cells were made permeable with saponin as described under
"Experimental Procedures." Representative images for at least five
experiments are shown.
|
|
Binding Properties of Long MLCK-GFP in Vivo--
To determine the
unique motif or module responsible for long MLCK binding to actin
filaments in vivo, expression vectors were constructed for
expression of GFP fusion proteins. The full-length long
MLCK-GFP showed binding to actin-containing stress fibers in
cells (Fig. 5A) confirming
previous observations on localization (19). Internal deletion of the
five DFRXXL motifs in the (-5 DFR) long MLCK-GFP construct
resulted in fluorescence associated with stress fibers with similar
results obtained in cells expressing only the N terminus of long MLCK
with six immunoglobulin modules but no DFRXXL motifs. The
five DFR-MLCK fragment by itself bound to actin-containing
stress fibers in NIH3T3 cells (Fig. 5), similar to results obtained in
A7r5 and HeLa cells (Fig. 4). Additional experiments showed that short
MLCK containing no DFRXXL motifs did not bind to
stress fibers (data not shown), confirming previously reported
observations (1, 18, 26). These results suggest that there are at least
two components in long MLCK involved in stress fiber binding: the five
DFRXXL motifs in addition to the N-terminal extension.

View larger version (96K):
[in this window]
[in a new window]
|
Fig. 5.
Binding of long MLCK-GFP and
its mutants to actin-containing stress fibers. NIH3T3 fibroblasts
were transfected for expression of long MLCK-GFP fusion
protein or various mutants including long MLCK with an internal
deletion of the 5 DRFXXL motifs ((-5DFR) long
MLCK-GFP), N-terminal fragment containing six
immunoglobulin-like modules without any DFRXXL motifs
((N-term) long MLCK-GFP), or a fragment containing only 5 DFRXXL motifs (5DFR-MLCK). The cells in the
middle and bottom rows were made permeable with
saponin, whereas the middle row shows GFP fluorescence and
the bottom row shows rhodamine-labeled phalloidin to reveal
actin-containing stress fibers. Representative images for at least five
experiments are shown.
|
|
Distributions of Long and Short MLCKs in Cell Fractions--
In an
effort to determine the relative affinities of MLCK isoforms for thin
filaments, concentrations of filamentous actin were affected in
transfected A7r5 cells treated with either lysophosphatidic acid or
latrunculin B. Lysates of treated cells were subjected to
centrifugation (Fig. 6). Following
treatment with 10 µM lysophosphatidic acid for 1 h
to stimulate actin polymerization, the short form of MLCK was
associated primarily with the low-speed pellet P1 and
supernatant fractions, although long MLCK was found only in the
P1 fraction. In addition, when cells were treated with
latrunculin B for 1 h to disassemble actin filaments, the short
form was distributed among P1, P2, and S
fractions. However, the long MLCK was still associated only with
P1. Similar results were obtained with NIH3T3 cells (data
not shown).

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 6.
Distribution of short and long MLCK-GFPs and
actin in cell fractions of A7r5 cells treated with lysophosphatidic
acid or latrunculin B. A, A7r5 cells transfected
with short or long MLCK-GFP were harvested after 48-72 h
with lysis buffer as described under "Experimental Procedures." The
lysates were centrifuged at 16,000 × g to obtain
pellet 1 (P1) and subsequently at 100,000 to obtain pellet
2 (P2) and supernatant (S) cellular fractions.
The cell fractions were resolved by SDS-PAGE (5%) and analyzed by
Western blotting with a monoclonal antibody against MLCK.
Representative blots for at least five experiments are shown.
B, A7r5 cells were transfected with short
MLCK-GFP and processed as described in A. Cell
samples were subjected to SDS-PAGE (10%) and analyzed by Western
blotting with a polyclonal antibody against actin. Representative blots
for at least three experiments are shown. C, A10 cells
expressing endogenous short and long MLCK were treated with
lysophosphatidic acid or latrunculin B and processed for Western
blotting as described in A. Representative blots for at
least three experiments are shown.
|
|
In contrast to MLCK, the distribution of the actin was altered by
1 h treatment with lysophosphatidic acid and latrunculin B (Fig.
6). When A7r5 cells were treated with lysophosphatidic acid, actin was
found primarily in P1 with some remaining in the supernatant fraction (S). However, treatment of cells with latrunculin B resulted in more actin in the supernatant fraction although a
significant portion still remained in P1 (Fig.
6B). Similar results were obtained with NIH3T3 cells treated
with lysophosphatidic acid or latrunculin B (data not shown).
Additionally, the total amount of actin was similar to nontreated cells.
To rule out effects of transfection or overexpression of short and long
MLCK on cellular distributions, the binding of endogenous short and
long MLCKs was examined in the smooth muscle cell line A10 that
contains each isoform. A10 cells in culture were incubated with
lysophosphatidic acid or latrunculin B as described above, and MLCK
distributions were measured in cellular fractions by Western blotting.
Fig. 6C shows that long MLCK was found exclusively in
P1 when cells were pretreated with lysophosphatidic acid or latrunculin B. In contrast, short MLCK was distributed among
P1, P2, and S when cells were treated with
lysophosphatidic acid. This distribution was not altered when the cells
were treated with latrunculin B. Thus, there was a difference between
the distribution of endogenous long MLCK versus short MLCK
in lysates of A10 cells treated with lysophosphatidic acid or
latrunculin B. However, the overall pattern is similar to that obtained
with transfected A7r5 and NIH3T3 cells. Collectively, these results
suggest that long MLCK has a greater affinity for actin-containing
filaments in cells.
Stress Fiber Localization of Long and Short MLCK in the Presence of
Lysophosphatidic Acid but Not Latrunculin B--
To visualize the
binding of the two MLCK isoforms to cellular actin filaments, A7r5
cells were transfected with either short or long MLCK-GFP.
In intact A7r5 cells pretreated with lysophosphatidic acid, short
MLCK-GFP binds to stress fibers. In addition, there was
diffuse fluorescence, which disappeared upon saponin treatment (Fig.
7). The phalloidin staining showed stress
fibers and confirmed colocalization with short MLCK (Fig. 7). In
contrast, when cells were treated with latrunculin B, they became
rounded and all fluorescence from short MLCK-GFP disappeared
after permeabilization. In addition, phalloidin staining showed no
stress fibers, although amorphous actin aggregates were apparent (Fig.
7). Similar to results obtained with short MLCK-GFP, the
long isoform was bound to stress fibers in intact A7r5 cells pretreated
with lysophosphatidic acid; however, a diffuse fluorescence was much
less apparent. The kinase remained bound after permeabilization and
phalloidin staining of the cells confirmed the colocalization of the
kinase with stress fibers. However, in cells pretreated with
latrunculin B, there was also no significant amount of fluorescence
remaining after permeabilization.

View larger version (125K):
[in this window]
[in a new window]
|
Fig. 7.
Cellular distribution of transfected short
and long MLCK-GFP in A7r5 cells. A7r5 cells grown
on glass coverslips were transfected with short (left
panels) or long (right panels) MLCK-GFP.
After 48-72 h intact cells were treated with 10 µM
lysophosphatidic acid (LPA) or 1 µM
latrunculin-B (Lat B) for 1 h before microscopic images
were obtained (top row). After images of intact cells were
obtained, cells were treated with a saponin-containing buffer as
described under "Experimental Procedures" (middle row).
Rhodamine-labeled phalloidin was then added to obtain images of actin
filaments (bottom row).
|
|
The apparent discrepancy between the biochemical results showing MLCKs
bound in the P1 fraction after latrunculin B treatment and
the cellular images demonstrating the absence of MLCK in permeable cells pretreated with latrunculin B was investigated. A7r5 cells transfected with short MLCK were pretreated with latrunculin
B, and the distribution of the kinase was examined by centrifugation between intact cells and cells that were treated first with saponin and
then washed. In permeable cells pretreated with latrunculin B, there
was a decrease in the total amount of kinase recovered after saponin
treatment and washing compared with intact cells (data not shown).
Thus, the washing procedure after saponin treatment appeared to remove
MLCK bound to actin filaments that were not anchored to the coverslip.
Long MLCK Binds to Cell Filaments with an Apparent Higher Affinity
Than the Short Isoform--
To examine differences in apparent binding
affinities of long and short MLCK for actin filaments, A10 cell lysates
and rabbit lung homogenates were incubated with various
MgCl2 concentrations to dissociate kinases from actin and
the amount of MLCK released into supernatant fractions after
centrifugation was determined by Western blotting. As the
MgCl2 concentration was increased from 0 to 10 mM in extracts of A10 cells, the short kinase was released
into the supernatant fraction (Fig.
8A). However, long MLCK
required 25 mM MgCl2 to be released into the
supernatant fraction. Similarly, in rabbit lung tissue homogenates the
short MLCK was found in the supernatant fractions at the lower
MgCl2 concentrations (Fig. 8B). Thus, the
extraction of MLCK by MgCl2 shows that the long isoform has
an apparent greater affinity for actin filaments than the short form.
These results are consistent with results obtained on the distributions
of short and long MLCKs in cell fractions after pretreatment with
lysophosphatidic acid or latrunculin B.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 8.
Long MLCK binds to actin
filaments with higher affinity than short MLCK. A,
lysates of A10 cells, or B, homogenates of rabbit lung
tissue were incubated with different MgCl2 concentrations
and centrifuged at 100,000 × g for 20 min at 4 °C.
Total and supernatant fractions were subjected to SDS-PAGE (5%) and
analyzed by Western blotting with a monoclonal antibody against MLCK.
The percentage of total short ( ) and long ( ) MLCK was quantified
from at least three different experiments. Values are mean ± S.E.
C, COS cells expressing different fragments of long and
short MLCKs were lysed for analysis of stress fiber binding as
described above. Short, long, 5DFR-MLCK, and 3DFR-MLCK were blotted
with K36 monoclonal antibody, whereas (-5DFR) long MLCK and (N-term)
long MLCK were blotted with anti-GFP antibody. Cell lysates were
incubated with 0, 2, or 50 mM MgCl2. Results
are expressed as percent of protein in supernatant fractions with 0 or
2 mM MgCl2 compared with amount present at 50 mM MgCl2.
|
|
Short and long MLCKs as well as selected fragments were
expressed in COS cells that are similar to HeLa cells with less stress fibers than A7r5 or A10 cells. Analysis of cell lysates incubated with
different concentrations of MgCl2 showed a greater
sensitivity for release of both short or long MLCKs than results
obtained with A10 cells (Fig. 8C). However, the relative
sensitivities were similar; the amount of short MLCK released into
supernatant fractions at lower MgCl2 concentrations was
greater than long MLCK. A similar relationship existed for 3DFR-MLCK
and 5DFR-MLCK. Interestingly, both (-5DFR) long MLCK and (N-term) long
MLCK showed some binding at 0 mM MgCl2 but were
completely released at 2 mM MgCl2, consistent
with weak binding to stress fibers. These results are qualitatively
consistent with results obtained with images of transfected NIH3T3
fibroblasts (Fig. 5). Because the fragment containing five
DFRXXL motifs binds as well as the two fragments from long
MLCK without DFRXXL motifs, we propose that two
binding regions in long MLCK may confer higher affinity to stress fibers.
 |
DISCUSSION |
We previously showed that the three DFRXXL motifs in
short MLCK were necessary and sufficient for high affinity
binding to actin-containing filaments (1, 16, 17). However, the
structural basis of long MLCK binding to actin-containing
filaments is not clear and there are differences in cellular
distributions between short and long MLCKs (11, 19). The N-terminal
extension of long MLCK with the six immunoglobulin-like modules plus
two DFRXXL motifs binds to actin-containing filaments (19).
However, it was not determined if this binding was because of
DFRXXL motifs, the immunoglobulin-like modules, or both
types of structures. In this study we constructed peptides of MLCK
consisting of either three or five DFRXXL motifs. These
constructs lack the downstream and upstream immunoglobulin-like modules
as well as the fibronectin module, structures proposed as candidates
for binding sites to other proteins. Our results show that 5DFR-MLCK
resembles 3DFR-MLCK in that it binds to actin-containing filaments with
high affinity. The stoichiometry of binding was less than 3DFR-MLCK but
consistent with each DFRXXL motif binding one actin monomer
in filaments. Thus, the two additional motifs in the long MLCK,
including the one that has a valine substituted for phenylalanine, also
appear to bind actin-containing filaments. The binding sites for each DFRXXL motif appear not to be competitive with other
F-actin-binding proteins in smooth muscle because the stoichiometries
were similar with purified F-actin or smooth muscle myofilaments. The
detergent-washed smooth muscle myofilaments contain the actin-binding
proteins tropomyosin, caldesmon, and calponin. In addition, myosin
binds to F-actin in the buffers lacking ATP. Thus, these results are consistent with the model derived from three-dimensional image reconstructions of each DFRXXL motif binding to a unique
site on actin filaments (16).
MLCK also acts as an actin bundling protein (22-24). Hayakawa
et al. (24) reported that MLCK had two actin-binding sites at Asp2-Pro41 and
Ser138-Met213 that were necessary for bundling.
A peptide containing both sites bundled actin, whereas peptides
containing only one site (residues 2-41 or 138-213) did not. However,
we found that MLCK peptides containing three or five actin-binding
motifs, but lacking the immunoglobulin and fibronectin modules present
in the larger peptide, were sufficient to bind to purified F-actin and
cross-link the filaments. Our MLCK peptide with only one actin-binding
motif was defective in assembling actin filaments, in agreement with their results (peptide containing residues 2-41 (24)). However, the
peptide that contained two DFRXXL motifs cross-linked actin filaments but to a lesser extent compared with the peptide containing three DFRXXL motifs. The apparent differences in
cross-linking may reflect differences in relative binding affinities of
the motifs because of interactions of residues surrounding core
DFRXXL motifs or because of differences in probability of
cross-linking dependent on the distance in spacing between the first
and second motif versus the first and third motif. However,
it is clear that multiple DFRXXL motifs in short peptides
are sufficient for actin cross-linking.
Both 3DFR-MLCK and 5DFR-MLCK bound prominently to actin stress fibers
in A7r5 smooth muscle cells. In contrast, the expression of
5DFR-MLCK in HeLa cells had more prominent fluorescence
associated with stress fibers compared with 3DFR-MLCK.
Poperechnaya et al. (19) demonstrated that short MLCK did
not bind prominently to actin stress fibers in HeLa cells, and there
was diffuse fluorescence, indicating a cytoplasmic distribution. The
differences in localization in different cell types may be because of
the relative abundance of actin-containing stress fibers or some
unidentified regulatory mechanism, such as phosphorylation (32) or
complementary interactions with residues in the extended N terminus of
long MLCK.
The long MLCK has a greater affinity for actin-containing filaments
than the short MLCK (19, 22). Cell fractionation studies of transfected
A7r5 cells and endogenously expressed kinase in A10 cells as well as
MgCl2 extraction of kinase from filaments in A10 cell
lysates and lung tissue homogenates support this conclusion. Poperechnaya et al. (19) found in interphase cells that
fusion of two additional DFRXXL motifs to short MLCK or
fusion of three DFRXXL motifs to the N-terminal extension of
the long MLCK fragment promoted binding to stress fibers compared with
short MLCK or the N-terminal fragment alone. Additionally, Kudryashova
et al. (22) found selective KCl extraction of short
versus long MLCKs from detergent-washed cytoskeletal
proteins, although the structural basis was not examined. Our results
show that the 5DFR-MLCK fragment binds to stress fibers. However, a
selective internal deletion of the five DFRXXL motifs in
long MLCK did not eliminate binding, and the N-terminal extension of
long MLCK without DFRXXL motifs also bound stress fibers.
The short MLCK lacking DFRXXL motifs does not bind. Thus,
long MLCK binding to stress fibers appears to be because of
complementary binding of five DFRXXL motifs plus the
N-terminal extension.
Cells in culture were treated with lysophosphatidic acid and
latrunculin B to promote or disrupt, respectively, stress fiber formation. Lysophosphatidic acid acting through its G protein-coupled receptor promotes stress fiber formation via a Rho-mediated pathway with enhancement of myosin light chain phosphorylation by inhibition of
myosin phosphatase (30). Latrunculin B disrupts actin polymerization by
sequestering monomeric actin in living cells (31). Morphological and
biochemical analyses of stress fiber formation in cells treated with
these reagents revealed qualitatively expected results. In cells
treated with lysophosphatidic acid, both short and long MLCK were bound
to stress fibers, but the short form showed significant amounts of
unbound kinase in contrast to the long MLCK. The apparent greater
affinity of long MLCK binding to filaments in vivo may be
because of the two additional DFRXXL motifs plus the
N-terminal extension, additional cooperative binding to other proteins
such as cortactin and p60src (32), or both.
The biochemical results obtained after treating cells with latrunculin
B were surprising considering the apparent disruption of stress fibers
observed microscopically. Others have noted latrunculin B treatment
results in disruption of stress fibers in cells in culture (33, 34).
After low-speed centrifugation in cells treated with latrunculin B,
actin shifted from being primarily in the pellet fraction to the
supernatant fraction. After latrunculin B treatment, the relative
distributions of either short or long MLCKs were not generally
affected. One possibility is that significant amounts of actin remain
in filaments for MLCK binding after latrunculin B treatment. However,
these actin filaments are not organized in stress fibers in cells and
are not attached to focal adhesions and other structures adhering to
the coverslip after detergent treatment. When cells were made permeable
with detergent, these actin filaments containing bound MLCKs may have
been removed with washing. Because the molar ratio of MLCK to actin in
filaments in cells is 1:100 or less (35, 36), disruption of most but not all actin filaments may not be sufficient to dissociate bound MLCKs. Additionally, MLCK may stabilize the actin filaments to which it
is bound so they are resistant to depolymerization.
In cells in culture, short MLCK distributes between bound and unbound
forms, and it is conceivable that both could phosphorylate myosin in
thick filaments. The length of the kinase, 41 to 54 nm for the chicken
and rabbit kinases, respectively (37), allows an extension of the
catalytic core from the actin filament to the myosin thick filament by
structural modules intervening between the actin-binding N terminus and
the catalytic C terminus. Bound, nondiffusing short MLCK phosphorylates
myosin light chain in a Ca2+/calmodulin-dependent manner in the
detergent-insoluble cytoskeleton (18). The long MLCK would be extended
similarly, because its larger size results from structural modules
N-terminal of the five DFRXXL actin-binding motifs. Thus,
bound forms of short and long MLCKs have structural modules placing
them in a unique position for
Ca2+/calmodulin-dependent signaling that leads
to myosin II-based motile events.
In summary, these results show that the cellular distributions of short
and long MLCKs are different. Whereas DFRXXL motifs are
necessary and sufficient for short MLCK binding to actin containing filaments, both DFRXXL motifs and the N-terminal extension
of long MLCK contribute to high affinity binding to actin-containing fibers in cells.
 |
ACKNOWLEDGEMENT |
We are thankful to Anne Bresnick for the
chicken long MLCK clone and helpful discussions.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant HL26093, Training Grant HD07190, and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
These authors contributed equally to this work.
§
Present address: Dept. of Biological Sciences, Alabama State
University, P.O. Box 271, Montgomery, AL 36101-0271.
¶
To whom correspondence should be addressed. Tel.:
214-648-6849; Fax: 214-648-2974; E-mail:
James.Stull@UTSouthwestern.edu.
Published, JBC Papers in Press, July 10, 2001, DOI 10.1074/jbc.M206483200
 |
ABBREVIATIONS |
The abbreviations used are:
MLCK, myosin light
chain kinase;
GST, glutathione S-transferase;
nt, nucleotide(s);
GFP, green fluorescent protein;
MOPS, 4-morpholinepropanesulfonic acid;
PIPES, 1,4-piperazinediethanesulfonic
acid.
 |
REFERENCES |
| 1.
|
Smith, L., Su, X.,
Lin, P.,
Zhi, G.,
and Stull, J. T.
(1999)
J. Biol. Chem.
274,
29433-29438[Abstract/Free Full Text]
|
| 2.
|
Kamm, K. E.,
and Stull, J. T.
(1985)
Annu. Rev. Pharmacol. Toxicol.
25,
593-620[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Gallagher, P. J.,
Herring, B. P.,
and Stull, J. T.
(1997)
J. Muscle Res. Cell Motil.
18,
1-16[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Kamm, K. E.,
and Stull, J. T.
(2001)
J. Biol. Chem.
276,
4527-4530[Free Full Text]
|
| 5.
|
Birukov, K. G.,
Schavocky, J. P.,
Shirinsky, V. P.,
Chibalina, M. V.,
Van Eldik, L. J.,
and Watterson, D. M.
(1998)
J. Cell. Biochem.
70,
402-413[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Watterson, D. M.,
Collinge, M.,
Lukas, T. J.,
Van Eldik, L. J.,
Birukov, K. G.,
Stepanova, O. V.,
and Shirinsky, V. P.
(1995)
FEBS Lett.
373,
217-220[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Potier, M.-C.,
Chelot, E.,
Pekarsky, Y.,
Gardiner, K.,
Rossier, J.,
and Turnell, W. G.
(1995)
Genomics
29,
562-570[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Fisher, S. A.,
and Ikebe, M.
(1995)
Biochem. Biophys. Res. Commun.
217,
696-703[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Jian, X.,
Szaro, B. G.,
and Schmidt, J. T.
(1996)
J. Neurobiol.
31,
379-391[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Kobayashi, H.,
Inoue, A.,
Mikawa, T.,
Kuwayama, H.,
Hotta, Y.,
Masaki, T.,
and Ebashi, S.
(1992)
J. Biochem. (Tokyo)
112,
786-791[Abstract/Free Full Text]
|
| 11.
|
Blue, E. K.,
Goeckeler, Z. M.,
Jin, Y.,
Hou, L.,
Dixon, S. A.,
Herring, B. P.,
Wysolmerski, R. B.,
and Gallagher, P. J.
(2002)
Am. J. Physiol.
282,
C451-C460[Abstract/Free Full Text]
|
| 12.
|
Davis, J. S.,
Hassanzadeh, S.,
Winitsky, S.,
Lin, H.,
Satorius, C.,
Vemuri, R.,
Aletras, A. H.,
Wen, H.,
and Epstein, N. D.
(2001)
Cell
107,
631-641[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Herring, B. P.,
Dixon, S.,
and Gallagher, P. J.
(2000)
Am. J. Physiol.
279,
C1656-C1664[Abstract/Free Full Text]
|
| 14.
|
Kanoh, S.,
Ito, M.,
Niwa, E.,
Kawano, Y.,
and Hartshorne, D. J.
(1993)
Biochemistry
32,
8902-8907[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Dabrowska, R.,
Hinkins, S.,
Walsh, M. P.,
and Hartshorne, D. J.
(1982)
Biochem. Biophys. Res. Commun.
107,
1524-1531[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Hatch, V.,
Zhi, G.,
Smith, L.,
Stull, J. T.,
Craig, R.,
and Lehman, W.
(2001)
J. Cell Biol.
154,
611-617[Abstract/Free Full Text]
|
| 17.
|
Smith, L.,
and Stull, J. T.
(2000)
FEBS Lett.
480,
298-300[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Lin, P.,
Luby-Phelps, K.,
and Stull, J. T.
(1999)
J. Biol. Chem.
274,
5987-5994[Abstract/Free Full Text]
|
| 19.
|
Poperechnaya, A.,
Varlamova, O.,
Lin, P. J.,
Stull, J. T.,
and Bresnick, A. R.
(2000)
J. Cell Biol.
151,
697-708[Abstract/Free Full Text]
|
| 20.
|
Sobue, K.,
and Sellers, J. R.
(1991)
J. Biol. Chem.
266,
12115-12118[Free Full Text]
|
| 21.
|
Pollard, T. D.,
and Cooper, J. A.
(1986)
Annu. Rev. Biochem.
55,
987-1035[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Kudryashov, D. S.,
Chibalina, M. V.,
Birukov, K. G.,
Lukas, T. J.,
Sellers, J. R.,
Van Eldik, L. J.,
Watterson, D. M.,
and Shirinsky, V. P.
(1999)
FEBS Lett.
463,
67-71[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Hayakawa, K.,
Okagaki, T.,
Higashi-Fujime, S.,
and Kohama, K.
(1994)
Biochem. Biophys. Res. Commun.
199,
786-791[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Hayakawa, K.,
Okagaki, T., Ye, L. H.,
Samizo, K.,
Higashi-Fujime, S.,
Takagi, T.,
and Kohama, K.
(1999)
Biochim. Biophys. Acta
1450,
12-24[Medline]
[Order article via Infotrieve]
|
| 25.
|
Pollard, T. D.,
Goldberg, I.,
and Schwarz, W. H.
(1992)
J. Biol. Chem.
267,
20339-20345[Abstract/Free Full Text]
|
| 26.
|
Lin, P.,
Luby-Phelps, K.,
and Stull, J. T.
(1997)
J. Biol. Chem.
272,
7412-7420[Abstract/Free Full Text]
|
| 27.
|
Watts, R. G.,
and Howard, T. H.
(1992)
Cell Motil. Cytoskeleton
21,
25-37[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Marston, S. B.,
and Redwood, C. S.
(1991)
Biochem. J.
279,
1-16
|
| 29.
|
Bretscher, A.
(1981)
Proc. Natl. Acad. Sci. U. S. A.
78,
6849-6853[Abstract/Free Full Text]
|
| 30.
|
Seasholtz, T. M.,
Majumdar, M.,
and Brown, J. H.
(1999)
Mol. Pharmacol.
55,
949-956[Free Full Text]
|
| 31.
|
Spector, I.,
Shochet, N. R.,
Blasberger, D.,
and Kashman, Y.
(1989)
Cell Motil. Cytoskeleton
13,
127-144[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Garcia, J. G.,
Verin, A. D.,
Schaphorst, K.,
Siddiqui, R.,
Patterson, C. E.,
Csortos, C.,
and Natarajan, V.
(1999)
Am. J. Physiol.
276,
L989-L998
|
| 33.
|
Bozem, M.,
Kuhlmann, S.,
Blum, R.,
Feick, P.,
and Schulz, I.
(2000)
Cell Calcium
28,
73-82[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Mack, C. P.,
Somlyo, A. V.,
Hautmann, M.,
Somlyo, A. P.,
and Owens, G. K.
(2001)
J. Biol. Chem.
276,
341-347[Abstract/Free Full Text]
|
| 35.
|
Hartshorne, D. J.
(1987)
in
Physiology of the Gastrointestinal Tract
(Johnson, L. R., ed), Second Ed.
, pp. 423-482, Raven Press, New York
|
| 36.
|
Tansey, M. G.,
Luby-Phelps, K.,
Kamm, K. E.,
and Stull, J. T.
(1994)
J. Biol. Chem.
269,
9912-9920[Abstract/Free Full Text]
|
| 37.
|
Numata, T.,
Katoh, T.,
and Yazawa, M.
(2001)
J. Biochem. (Tokyo)
129,
437-444[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. R. Injeti, R. J. Sandoval, J. M. Williams, A. V. Smolensky, L. E. Ford, and W. J. Pearce
Maximal stimulation-induced in situ myosin light chain kinase activity is upregulated in fetal compared with adult ovine carotid arteries
Am J Physiol Heart Circ Physiol,
December 1, 2008;
295(6):
H2289 - H2298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Takizawa, R. Ikebe, M. Ikebe, and E. J. Luna
Supervillin slows cell spreading by facilitating myosin II activation at the cell periphery
J. Cell Sci.,
November 1, 2007;
120(21):
3792 - 3803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Ranaivo, N. Carusio, R. Wangensteen, P. Ohlmann, C. Loichot, A. Tesse, K. Chalupsky, I. Lobysheva, J. Haiech, D. M. Watterson, et al.
Protection Against Endotoxic Shock as a Consequence of Reduced Nitrosative Stress in MLCK210-Null Mice
Am. J. Pathol.,
February 1, 2007;
170(2):
439 - 446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ohlmann, A. Tesse, C. Loichot, H. R. Ranaivo, G. Roul, C. Philippe, D. M. Watterson, J. Haiech, and R. Andriantsitohaina
Deletion of MLCK210 induces subtle changes in vascular reactivity but does not affect cardiac function
Am J Physiol Heart Circ Physiol,
December 1, 2005;
289(6):
H2342 - H2349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. G. Dulyaninova, Y. V. Patskovsky, and A. R. Bresnick
The N-terminus of the long MLCK induces a disruption in normal spindle morphology and metaphase arrest
J. Cell Sci.,
March 15, 2004;
117(8):
1481 - 1493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. SOMLYO and A. V. SOMLYO
Ca2+ Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
Physiol Rev,
October 1, 2003;
83(4):
1325 - 1358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Smith, M. Bracke, B. Leitinger, J. C. Porter, and N. Hogg
LFA-1-induced T cell migration on ICAM-1 involves regulation of MLCK-mediated attachment and ROCK-dependent detachment
J. Cell Sci.,
August 1, 2003;
116(15):
3123 - 3133.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|